Home » Topics » Regulatory » Patents

Patents
RSS

Il Yang develops antitumor/immunostimulating proteoglycan

Feb. 7, 1997

Rockefeller University discloses antibiotic peptides

Feb. 7, 1997

Merck describes improved chemotherapeutic agents

Feb. 7, 1997

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Feb. 7, 1997

Tsumura describes agents for dermatitis

Feb. 7, 1997

Chymase inhibitors from Green Cross

Feb. 7, 1997

BASF discloses antithrombotic from ticks

Feb. 6, 1997

BTG describes immunosuppressive antibodies

Feb. 6, 1997

Egis develops 5-LO inhibitors

Feb. 6, 1997

Antitumor prodrugs for ADEPT from Pharmachemie

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...